MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a neurodegenerative disorder characterised by amyloid beta (Aβ) deposits in the brain and the intracellular accumulation of neurofibrillary tangles of hyperphosphorylated tau protein (p-tau).